Immunome (IMNM)
(Delayed Data from NSDQ)
$9.39 USD
-0.46 (-4.67%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $9.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Immunome, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMNM 9.39 -0.46(-4.67%)
Will IMNM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IMNM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMNM
Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates
IMNM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy?
Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss, Misses Revenue Estimates
Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock?
Other News for IMNM
Crossed Above 20 Day Moving Average appears for IMNM after 9.57% move
Immunome (IMNM) Enters Collaboration with Infinimmune for Antibody Discovery
IMNM forms NR7 on September 17
Immunome announces novel antibody collaboration with Infinimmune
Immunome announces novel antibody collaboration with Infinimmune